Synergistic chemosensitization and inhibition of tumor growth and metastasis by adenovirus-mediated p53 gene transfer in human bladder cancer model
- 1 August 2000
- Vol. 56 (2) , 332-336
- https://doi.org/10.1016/s0090-4295(00)00567-7
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Chemosensitization and Delayed Androgen-Independent Recurrence of Prostate Cancer With the Use of Antisense Bcl-2 OligodeoxynucleotidesJNCI Journal of the National Cancer Institute, 2000
- CALCIUM IONOPHORE, IONOMYCIN INHIBITS GROWTH OF HUMAN BLADDER CANCER CELLS BOTH IN VITRO AND IN VIVO WITH ALTERATION OF BCL-2 AND BAX EXPRESSION LEVELSJournal of Urology, 1999
- Overexpression of Bcl-2 enhances metastatic potential of human bladder cancer cellsBritish Journal of Cancer, 1999
- Overexpression of Bcl-2 in bladder cancer cells inhibits apoptosis induced by cisplatin and adenoviral-mediated p53 gene transferOncogene, 1998
- Basic Fibroblast Growth Factor Regulates Matrix Metalloproteinases Production and In Vitro Invasiveness in Human Bladder Cancer Cell LinesJournal of Urology, 1997
- Adenovirus-mediated suicide gene therapy for experimental bladder cancerUrology, 1997
- Adenoviral - P53 Gene Transfer to Orthotopic and Peritoneal Murine Bladder CancerJournal of Urology, 1996
- Intravesical administration of indium‐111‐labelled hmfg2 monoclonal antibody in superficial bladder carcinomasInternational Journal of Cancer, 1993
- Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapseCancer, 1989
- Preliminary Results of M-VAC (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) for Transitional Cell Carcinoma of the UrotheliumJournal of Urology, 1985